Alcon
About: Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
Employees: 25,599
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
25% more funds holding in top 10
Funds holding in top 10: 12 [Q4 2024] → 15 (+3) [Q1 2025]
5% more capital invested
Capital invested by funds: $22.2B [Q4 2024] → $23.4B (+$1.17B) [Q1 2025]
9% more first-time investments, than exits
New positions opened: 76 | Existing positions closed: 70
2% less funds holding
Funds holding: 645 [Q4 2024] → 633 (-12) [Q1 2025]
5.38% less ownership
Funds ownership: 53.07% [Q4 2024] → 47.69% (-5.38%) [Q1 2025]
11% less repeat investments, than reductions
Existing positions increased: 193 | Existing positions reduced: 217
33% less call options, than puts
Call options by funds: $226M | Put options by funds: $340M
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
4 analyst ratings
Needham David Saxon | 26%upside $110 | Buy Reiterated | 14 May 2025 |
Keybanc Brett Fishbin | 28%upside $112 | Overweight Maintained | 31 Mar 2025 |
Mizuho Anthony Petrone | 37%upside $120 | Outperform Maintained | 28 Mar 2025 |
Baird Jeff Johnson | 23%upside $108 | Outperform Maintained | 27 Feb 2025 |
Financial journalist opinion
Based on 8 articles about ALC published over the past 30 days









